CareLit · DOI-Nachweis · Aktuelle Neurologie
Conditional control of human wildtype and mutated [A30P] alpha-synuclein in a mouse model of Parkinson's disease
DOI 10.1055/s-2005-919318
Bibliografische Angaben
Nachweis in CareLit
Autor:innenS Nuber, T Schmidt, H.W Habbes, M Löbbecke-Schumacher, P Teismann, J.B Schulz, B.J Pichler, M Neumann, M Fendt, D Berg, C Holzmann, U Grasshoff, J Boy, I Schmitt, A Bornemann, F Zimmermann, W Kuhn, S Prusiner, E Petrasch-Parwez, O Riess
ZeitschriftAktuelle Neurologie
Ausgabe10/2005
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Alpha-synuclein, a small soluble protein is expressed primarily at presynaptic terminals in the central nervous system. It has been implicated in the pathophysiology of many neurodegenerative disorders, including Parkinson's disease and dementia with Lewy-bodies, collectively referred to as synucleinopathies. As neurodegenerative disorders like Parkinson's disease are charecterized by progressive neuropathological a…
Zitieren
Zitierempfehlung
S Nuber, T Schmidt, H.W Habbes, M Löbbecke-Schumacher, P Teismann, J.B Schulz, B.J Pichler, M Neumann, M Fendt, D Berg, C Holzmann, U Grasshoff, J Boy, I Schmitt, A Bornemann, F Zimmermann, W Kuhn, S Prusiner, E Petrasch-Parwez, O Riess (2005) Conditional control of human wildtype and mutated [A30P] alpha-synuclein in a mouse model of Parkinson's disease. Aktuelle Neurologie (10). https://doi.org/10.1055/s-2005-919318
Mit CareLit weiterarbeiten